Labocanna

Labocanna OCF/Debt

The Operating Cash Flow to Debt Ratio of Labocanna (LCN.WA) as of Oct 19, 2026 is -6,891.63 %. In the previous year, Operating Cash Flow to Debt Ratio was -52.56 % — a change of 13,010.91% (lower).

OCF/Debt

-6,891.63 %

YoY

13,010.91%

Last updated:

Operating Cash Flow to Debt Ratio of Labocanna is 2022 -6,891.63 % . Operating Cash Flow to Debt Ratio of Labocanna was 2021 -52.56 % . It decreases by 13,010.91% lower compared to the previous year.

The Labocanna OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2015
123.53 PLN
Jan 1, 2016
18.00 PLN
Jan 1, 2017
-143.55 PLN
Jan 1, 2018
-63.33 PLN
Jan 1, 2019
5.17 PLN
Jan 1, 2020
0.00 PLN
Jan 1, 2021
-52.56 PLN
Jan 1, 2022
-6,891.63 PLN
The Labocanna OCF/Debt history
YEAROCF/DebtYoY
-6,891.63 %+13,010.91%
-52.56 %—
0.00-100.00%
5.17 %-108.17%
-63.33 %-55.88%
-143.55 %-897.49%
18.00 %-85.43%
123.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

Operating Cash Flow to Debt Ratio of Labocanna is -6,891.63 % in 2022.

Operating Cash Flow to Debt Ratio of Labocanna changed from -52.56 % to -6,891.63 %, representing a 13,010.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Labocanna since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Labocanna with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Labocanna

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Labocanna